Intestinal Ischemia Biomarker in Patients With Chronic Mesenteric Ischemia

RecruitingOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

June 10, 2024

Primary Completion Date

May 31, 2037

Study Completion Date

May 31, 2037

Conditions
Chronic Mesenteric IschemiaMedian Arcuate Ligament SyndromeCrohn DiseaseCholelithiasis
Interventions
PROCEDURE

Laparoscopic surgery

"The patients in the MALS group will be treated through transperitoneal ventral approach for the laparoscopic release of the celiac artery. Median arcuate ligament and any muscle or nerve tissue crossing the cranial surface of the celiac artery will be divided to release the celiac artery from compression.~In the patients with CMI open antegrade or retrograde bypass to celiac artery or superior mesenteric artery or both will be performed.~For operative treatment will be performed in general anaethesia whereas the endovacular treatment with PTA with stent for CMI will be performed in local anaethesia."

Trial Locations (1)

Unknown

RECRUITING

Department of vascular surgery, Oslo University Hospital, Oslo

All Listed Sponsors
lead

Oslo University Hospital

OTHER

NCT06468774 - Intestinal Ischemia Biomarker in Patients With Chronic Mesenteric Ischemia | Biotech Hunter | Biotech Hunter